Literature DB >> 15848463

Donor kidneys with small renal cell cancers: can they be transplanted?

J F Buell1, M J Hanaway, M Thomas, R Munda, R R Alloway, M R First, E S Woodle.   

Abstract

INTRODUCTION: The purpose of this study was to determine whether incidentally discovered, small renal cell cancers (RCC) in donor kidneys can be excised and safely transplanted.
METHODS: The Israel Penn International Transplant Tumor Registry database was searched and all small RCC that were identified and resected prior to transplantation of deceased and living donor kidneys were reviewed. Patient demographics, tumor characteristics, recurrence, and survival were examined.
RESULTS: Fourteen kidneys were identified in which small RCC were noted at the time of procurement and where the tumors were excised ex vivo and then transplanted. Eleven kidneys were obtained from living related donors and three were from deceased donors. Median tumor size was 2 cm (range 0.5 to 4 cm). All 14 tumors were of histological Furhman grade II/VI (n = 8) or Furhman grade I/VI (n = 6). All kidneys had pathologically confirmed negative margins. The mean age of the recipients was 40.8 +/- 9.2 years, with the majority being men (11 men; 3 women). Median follow-up for this group was 69 months (range 14 to 200 months). There have been no recurrences of tumor in these recipients and the 1-, 3-, and 5-year patient and graft survivals are 100%, 100%, and 93%.
CONCLUSIONS: These data represent the only data available (to our knowledge) on this issue. This experience indicates that donor kidneys with small, incidental RCC and low histological grade (Furhman grade I and II/IV) can be managed with excision and transplantation, with a low risk of tumor recurrence in the recipient.

Entities:  

Mesh:

Year:  2005        PMID: 15848463     DOI: 10.1016/j.transproceed.2004.12.118

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  The Ethics of the Reuse of Disposable Medical Supplies.

Authors:  Anjan Kumar Das; Taketoshi Okita; Aya Enzo; Atsushi Asai
Journal:  Asian Bioeth Rev       Date:  2020-04-12

2.  Living-donor transplantation after excision of unrecognized renal cancer diagnosed after transplant.

Authors:  Marta Melgosa Hijosa; Angel Alonso Melgar; Ma José Martínez Urrutia; Carmen García Meseguer; Enrique Jaureguizar Monereo; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2012-07-18       Impact factor: 3.714

Review 3.  Use of Kidneys with Small Renal Tumors for Transplantation.

Authors:  Alejandro Lugo-Baruqui; Giselle Guerra; Adriana Arocha; George W Burke; Gaetano Ciancio
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

4.  Expanding living kidney donor criteria with ex-vivo surgery for renal anomalies.

Authors:  Thomas B McGregor; Christie Rampersad; Premal Patel
Journal:  Can Urol Assoc J       Date:  2016 Sep-Oct       Impact factor: 1.862

5.  [Urological follow-up and development of cancer after renal transplantation].

Authors:  M Giessing
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

6.  [Malignant neoplasms and kidney transplantation].

Authors:  H Heynemann; A Hamza; S Wagner; R Hoda; A Schumann; P Fornara
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

7.  Detection and management of renal cell carcinoma in the renal allograft.

Authors:  Gyula Végső; Éva Toronyi; Pál Ákos Deák; Attila Doros; Róbert Miklós Langer
Journal:  Int Urol Nephrol       Date:  2012-09-01       Impact factor: 2.370

8.  Renal transplantation with kidneys affected by tumours.

Authors:  Muhammad Arslan Khurram; Aliu Oladipupo Sanni; David Rix; David Talbot
Journal:  Int J Nephrol       Date:  2011-01-18

9.  Algorithm for Bosniak 2F Cyst in Kidney Donation.

Authors:  Robert C Minnee; Hendrikus J A N Kimenai; Paul C Verhagen; Jan H von der Thüsen; Roy S Dwarkasing; Jacqueline van de Wetering; Jan N IJzermans
Journal:  Am J Case Rep       Date:  2017-06-30

10.  Benign and malignant renal cells are differentially inhibited during prolonged organ preservation.

Authors:  Nengwang Yu; Shuai Fu; Yubao Liu; Yibao Liu; Zhihou Fu; Jianzhong Meng; Zhonghua Xu; Baocheng Wang; Aimin Zhang
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.